Drugs / DXM
last change Dec 2020 re-read 2 minutes ago

DXM

Developed for
precursor lymphoblastic lymphoma/leukemia
Investigated by
GIMEMA Foundation

Trials 1 · a red edge is where a trial was stopped

2015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT02067143 May 2014 → Oct 2016 precursor lymphoblastic lymphoma/leukemia GIMEMA Foundation Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as DXM “VCR + IDR + DXM + ASP + IT” NCT02067143